Cargando…

Interleukin-18, interleukin-20, and matrix metalloproteinases (MMP-1, MMP-3) as markers of psoriatic arthritis disease severity and their correlations with biomarkers of inflammation and turnover of joint cartilage

INTRODUCTION: Psoriatic arthritis (PsA) is a chronic, seronegative spondyloarthropathy characterised by joint inflammation and psoriatic skin changes. Recent data indicate that interleukin-18 (IL-18) and interleukin-20 (IL-20) may be involved in the aetiopathogenesis of PsA. AIM: To evaluate the pot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Waszczykowski, Michał, Bednarski, Igor, Narbutt, Joanna, Waszczykowska, Elżbieta, Lesiak, Aleksandra, Fabiś, Jarosław
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2020
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874883/ https://www.ncbi.nlm.nih.gov/pubmed/33603622 http://dx.doi.org/10.5114/ada.2020.94903

Ejemplares similares

The influence of tumour necrosis factor α inhibitors treatment – etanercept on serum concentration of biomarkers of inflammation and cartilage turnover in psoriatic arthritis patients
por: Waszczykowski, Michał, et al.
Publicado: (2020)

Serum and synovial fluid concentrations of interleukin-18 and interleukin-20 in patients with osteoarthritis of the knee and their correlation with other markers of inflammation and turnover of joint cartilage
por: Waszczykowski, Michał, et al.
Publicado: (2020)

Serum Biomarkers of Inflammation and Turnover of Joint Cartilage Can Help Differentiate Psoriatic Arthritis (PsA) Patients from Osteoarthritis (OA) Patients
por: Waszczykowski, Michał, et al.
Publicado: (2020)

Matrix Metalloproteinases MMP-2 and MMP-9, Their Inhibitors TIMP-1 and TIMP-2, Vascular Endothelial Growth Factor and sVEGFR-2 as Predictive Markers of Ischemic Retinopathy in Patients with Systemic Sclerosis—Case Series Report
por: Waszczykowska, Arleta, et al.
Publicado: (2020)

Selected Matrix Metalloproteinases (MMP-2, MMP-7) and Their Inhibitor (TIMP-2) in Adult and Pediatric Cancer
por: Kaczorowska, Aleksandra, et al.
Publicado: (2020)

Assessment of apoptosis and MMP-1, MMP-3 and TIMP-2 expression in tibial hyaline cartilage after viable medial meniscus transplantation in the rabbit
por: Zwierzchowski, Tomasz J., et al.
Publicado: (2012)

Quantification of matrix metalloproteinases MMP-8 and MMP-9 in gingival overgrowth
por: Orozco-Páez, Jennifer, et al.
Publicado: (2021)

Role of Matrix Metalloproteinase (MMP) 2 and MMP-9 in Soft Tissue Sarcoma
por: Yang, Hyun Kee, et al.
Publicado: (2014)

The Significance of Matrix Metalloproteinase 9 (MMP-9) and Metalloproteinase 2 (MMP-2) in Urinary Bladder Cancer
por: Kudelski, Jacek, et al.
Publicado: (2023)

Expressions of Matrix Metalloproteinases (MMP-2, MMP-7, and MMP-9) and Their Inhibitors (TIMP-1, TIMP-2) in Inflammatory Bowel Diseases
por: Jakubowska, Katarzyna, et al.
Publicado: (2016)

Serum concentration of matrix metalloproteinases and angiogenic factors in patients with venous leg ulcers
por: Kolano, Paweł, et al.
Publicado: (2021)

Expression and function of matrix metalloproteinase (MMP)-28
por: Rodgers, Ursula R., et al.
Publicado: (2009)

The Role of Matrix Metalloproteinases (MMP-8, MMP-9, MMP-13) in Periodontal and Peri-Implant Pathological Processes
por: Luchian, Ionut, et al.
Publicado: (2022)

Correlation between expression of matrix metalloproteinase-2 (MMP-2), and matrix metalloproteinase-9 (MMP-9) and angiogenesis in colorectal adenocarcinoma.
por: Kim, T. S., et al.
Publicado: (1999)

Interleukin-4 inhibition of interleukin-1-induced expression of matrix metalloproteinase-3 (MMP-3) is independent of lipoxygenase and PPARγ activation in human gingival fibroblasts
por: Stewart, Denise, et al.
Publicado: (2007)

Altered Maternal Serum Matrix Metalloproteinases MMP-2, MMP-3, MMP-9, and MMP-13 in Severe Early- and Late-Onset Preeclampsia
por: Laskowska, Marzena
Publicado: (2017)

Matrix metalloproteinases in human gliomas: activation of matrix metalloproteinase-2 (MMP-2) may be correlated with membrane-type-1 matrix metalloproteinase (MT1-MMP) expression.
por: Hur, J. H., et al.
Publicado: (2000)

FTY-720P Suppresses Osteoclast Formation by Regulating Expression of Interleukin-6 (IL-6), Interleukin-4 (IL-4), and Matrix Metalloproteinase 2 (MMP-2)
por: Zhang, Dawei, et al.
Publicado: (2016)

Matrix metalloproteinases (MMP’s) in the rat scoliotic intervertebral disc
por: Grivas, Theodoros B, et al.
Publicado: (2010)

Matrix Metalloproteinases MMP-2 and MMP-9 Occupy a New Role in Severe Preeclampsia
por: Timokhina, Elena, et al.
Publicado: (2020)

Role and effectiveness of complex and supervised rehabilitation on overall and hand function in systemic sclerosis patients—one-year follow-up study
por: Waszczykowski, Michał, et al.
Publicado: (2021)

MMP-1, MMP-3 and MMP-10 are involved in the degradation of cartilage
por: Tolboom, TCA, et al.
Publicado: (2001)

Interleukin-6 increases matrix metalloproteinase-14 (MMP-14) levels via down-regulation of p53 to drive cancer progression
por: Cathcart, Jillian M., et al.
Publicado: (2016)

Matrix Metalloproteinase-9 (MMP-9) as a Cancer Biomarker and MMP-9 Biosensors: Recent Advances
por: Huang, Hao
Publicado: (2018)

Are interleukin-15 and -22 a new pathogenic factor in pustular palmoplantar psoriasis?
por: Lesiak, Aleksandra, et al.
Publicado: (2016)

Narrow band ultraviolet B irradiations cause alteration in interleukin-31 serum level in psoriatic patients
por: Narbutt, Joanna, et al.
Publicado: (2012)

Matrix Metalloproteinases in Oral Health—Special Attention on MMP-8
por: Atanasova, Tsvetelina, et al.
Publicado: (2023)

Enhanced Expression but Decreased Specific Activity of Matrix Metalloproteinase 10 (MMP-10) in Comparison with Matrix Metalloproteinase 3 (MMP-3) in Human Urinary Bladder Carcinoma
por: Kudelski, Jacek, et al.
Publicado: (2021)

Matrix Metalloproteinases MMP2 and MMP9 Are Produced in Early Stages of Kidney Morphogenesis but Only MMP9 Is Required for Renal Organogenesis In Vitro
por: Lelongt, Brigitte, et al.
Publicado: (1997)

Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma.
por: Sier, C. F., et al.
Publicado: (1996)

Levels of plasma matrix metalloproteinases (MMP-2 and MMP-9) in response to INTEGRA(®) dermal regeneration template implantation
por: Nessler, MichałBohdan, et al.
Publicado: (2014)

Developmental expression of membrane type 4-matrix metalloproteinase (Mt4-mmp/Mmp17) in the mouse embryo
por: Blanco, María José, et al.
Publicado: (2017)

Natural Marine and Terrestrial Compounds as Modulators of Matrix Metalloproteinases-2 (MMP-2) and MMP-9 in Alzheimer’s Disease
por: Ciccone, Lidia, et al.
Publicado: (2021)

Dynamic Expression of Membrane Type 1-Matrix Metalloproteinase (Mt1-mmp/Mmp14) in the Mouse Embryo
por: Muñoz-Sáez, Emma, et al.
Publicado: (2021)

Quercetin Inhibits the Migration and Invasion of HCCLM3 Cells by Suppressing the Expression of p-Akt1, Matrix Metalloproteinase (MMP) MMP-2, and MMP-9
por: Lu, Jun, et al.
Publicado: (2018)

133 Corticosteroid Rreatment Reduces Tissue Eosinophilia and the Expression of Matrix Metalloproteinases (MMP-1, MMP-2, MMP-7, MMP-9) and Their Tissue Inhibitor (TIMP-1) in Nasal Polyps
por: de Borja Callejas, Fco, et al.
Publicado: (2012)

Expression of metalloproteinases (MMP-2 and MMP-9) in basal-cell carcinoma
por: Goździalska, Anna, et al.
Publicado: (2016)

Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma
por: Talvensaari-Mattila, A, et al.
Publicado: (2003)

Matrix Metalloproteinase-9 (MMP-9) Gene Polymorphism in Stroke Patients
por: Buraczynska, Kinga, et al.
Publicado: (2015)

Expression and prognostic impact of matrix metalloproteinase-2 (MMP-2) in astrocytomas
por: Ramachandran, Rahimsan K., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_f88r9rcpn29uh674av4e6mugd3